Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma.

van der Tuin K, Ventayol Garcia M, Corver WE, Khalifa MN, Ruano Neto D, Corssmit EPM, Hes FJ, Links TP, Smit JWA, Plantinga TS, Kapiteijn E, van Wezel T, Morreau H.

Eur J Endocrinol. 2019 Apr 1;180(4):235-241. doi: 10.1530/EJE-18-0653.

PMID:
30668525
2.

Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies.

Kostine M, Briaire-de Bruijn IH, Cleven AHG, Vervat C, Corver WE, Schilham MW, Van Beelen E, van Boven H, Haas RL, Italiano A, Cleton-Jansen AM, Bovée JVMG.

Oncoimmunology. 2017 Oct 26;7(2):e1386828. doi: 10.1080/2162402X.2017.1386828. eCollection 2018.

3.

L1 cell adhesion molecule (L1CAM) is a strong predictor for locoregional recurrences in cervical cancer.

Schrevel M, Corver WE, Vegter ME, Ter Haar NT, Dreef EJ, Beltman JJ, Kenter G, Bosse T, de Kroon CD, Jordanova ES.

Oncotarget. 2017 Sep 18;8(50):87568-87581. doi: 10.18632/oncotarget.20976. eCollection 2017 Oct 20.

4.

ROS-induced near-homozygous genomes in thyroid cancer.

Corver WE, Demmers J, Oosting J, Sahraeian S, Boot A, Ruano D, Wezel TV, Morreau H.

Endocr Relat Cancer. 2018 Jan;25(1):83-97. doi: 10.1530/ERC-17-0288. Epub 2017 Oct 24.

PMID:
29066502
5.

High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth.

de Graaff MA, Malu S, Guardiola I, Kruisselbrink AB, de Jong Y, Corver WE, Gelderblom H, Hwu P, Nielsen TO, Lazar AJ, Somaiah N, Bovée JVMG.

Transl Oncol. 2017 Aug;10(4):546-554. doi: 10.1016/j.tranon.2017.05.007. Epub 2017 Jun 24.

6.

Chemosensitivity of BRCA1-Mutated Ovarian Cancer Cells and Established Cytotoxic Agents.

van Haaften C, van Eendenburg J, Boot A, Corver WE, Haans L, van Wezel T, Trimbos JB.

Int J Gynecol Cancer. 2017 Oct;27(8):1571-1578. doi: 10.1097/IGC.0000000000001052.

PMID:
28604461
7.

Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma.

Sand LGL, Buckle T, van Leeuwen FWB, Corver WE, Kruisselbrink AB, Jochemsen AG, Hogendoorn PCW, Szuhai K.

BMC Cancer. 2017 May 26;17(1):383. doi: 10.1186/s12885-017-3352-z.

8.

Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial.

Schneider TC, de Wit D, Links TP, van Erp NP, van der Hoeven JJ, Gelderblom H, Roozen IC, Bos M, Corver WE, van Wezel T, Smit JW, Morreau H, Guchelaar HJ, Kapiteijn E.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):698-707. doi: 10.1210/jc.2016-2525. Erratum in: J Clin Endocrinol Metab. 2017 Jun 1;102(6):2125.

PMID:
27870581
9.

Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiers.

Hoekstra AS, Addie RD, Ras C, Seifar RM, Ruivenkamp CA, Briaire-de Bruijn IH, Hes FJ, Jansen JC, Corssmit EP, Corver WE, Morreau H, Bovée JV, Bayley JP, Devilee P.

Hum Mol Genet. 2016 Sep 1;25(17):3715-3728. doi: 10.1093/hmg/ddw218. Epub 2016 Jul 8.

PMID:
27402879
10.

Imprinted survival genes preclude loss of heterozygosity of chromosome 7 in cancer cells.

Boot A, Oosting J, de Miranda NF, Zhang Y, Corver WE, van de Water B, Morreau H, van Wezel T.

J Pathol. 2016 Sep;240(1):72-83. doi: 10.1002/path.4756.

PMID:
27265324
11.

Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population.

Lugthart G, Melsen JE, Vervat C, van Ostaijen-Ten Dam MM, Corver WE, Roelen DL, van Bergen J, van Tol MJ, Lankester AC, Schilham MW.

J Immunol. 2016 Jul 1;197(1):78-84. doi: 10.4049/jimmunol.1502603. Epub 2016 May 25.

12.

Digital Sorting of Pure Cell Populations Enables Unambiguous Genetic Analysis of Heterogeneous Formalin-Fixed Paraffin-Embedded Tumors by Next Generation Sequencing.

Bolognesi C, Forcato C, Buson G, Fontana F, Mangano C, Doffini A, Sero V, Lanzellotto R, Signorini G, Calanca A, Sergio M, Romano R, Gianni S, Medoro G, Giorgini G, Morreau H, Barberis M, Corver WE, Manaresi N.

Sci Rep. 2016 Feb 11;6:20944. doi: 10.1038/srep20944.

13.

Osteosarcoma Stem Cells Have Active Wnt/β-catenin and Overexpress SOX2 and KLF4.

Martins-Neves SR, Corver WE, Paiva-Oliveira DI, van den Akker BE, Briaire-de-Bruijn IH, Bovée JV, Gomes CM, Cleton-Jansen AM.

J Cell Physiol. 2016 Apr;231(4):876-86. doi: 10.1002/jcp.25179. Epub 2015 Sep 9.

PMID:
26332365
14.

Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.

Punt S, Corver WE, van der Zeeuw SA, Kielbasa SM, Osse EM, Buermans HP, de Kroon CD, Jordanova ES, Gorter A.

Oncotarget. 2015 Nov 17;6(36):38681-94. doi: 10.18632/oncotarget.4526.

15.

Copy number alterations and allelic ratio in relation to recurrence of rectal cancer.

Goossens-Beumer IJ, Oosting J, Corver WE, Janssen MJ, Janssen B, van Workum W, Zeestraten EC, van de Velde CJ, Morreau H, Kuppen PJ, van Wezel T.

BMC Genomics. 2015 Jun 6;16:438. doi: 10.1186/s12864-015-1550-0.

16.

Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells.

van Haaften C, Boot A, Corver WE, van Eendenburg JD, Trimbos BJ, van Wezel T.

J Exp Clin Cancer Res. 2015 Apr 25;34:38. doi: 10.1186/s13046-015-0157-2.

17.

Spontaneous bone metastases in a preclinical orthotopic model of invasive lobular carcinoma; the effect of pharmacological targeting TGFβ receptor I kinase.

Buijs JT, Matula KM, Cheung H, Kruithof-de Julio M, van der Mark MH, Snoeks TJ, Cohen R, Corver WE, Mohammad KS, Jonkers J, Guise TA, van der Pluijm G.

J Pathol. 2015 Apr;235(5):745-59. doi: 10.1002/path.4488. Epub 2015 Jan 23.

18.

Towards imaging metabolic pathways in tissues.

Dekker TJ, Jones EA, Corver WE, van Zeijl RJ, Deelder AM, Tollenaar RA, Mesker WE, Morreau H, McDonnell LA.

Anal Bioanal Chem. 2015 Mar;407(8):2167-76. doi: 10.1007/s00216-014-8305-7. Epub 2014 Nov 9.

PMID:
25381617
19.

Near-haploidization significantly associates with oncocytic adrenocortical, thyroid, and parathyroid tumors but not with mitochondrial DNA mutations.

Corver WE, van Wezel T, Molenaar K, Schrumpf M, van den Akker B, van Eijk R, Ruano Neto D, Oosting J, Morreau H.

Genes Chromosomes Cancer. 2014 Oct;53(10):833-44. doi: 10.1002/gcc.22194. Epub 2014 Jun 7.

PMID:
24909752
20.

MicroRNA profiling of primary cutaneous large B-cell lymphomas.

Koens L, Qin Y, Leung WY, Corver WE, Jansen PM, Willemze R, Vermeer MH, Tensen CP.

PLoS One. 2013 Dec 16;8(12):e82471. doi: 10.1371/journal.pone.0082471. eCollection 2013.

21.

Loss of heterozygosity and copy number alterations in flow-sorted bulky cervical cancer.

van den Tillaart SA, Corver WE, Ruano Neto D, ter Haar NT, Goeman JJ, Trimbos JB, Fleuren GJ, Oosting J.

PLoS One. 2013 Jul 9;8(7):e67414. doi: 10.1371/journal.pone.0067414. Print 2013.

22.

Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer.

Sarasqueta AF, Forte G, Corver WE, de Miranda NF, Ruano D, van Eijk R, Oosting J, Tollenaar RA, van Wezel T, Morreau H.

BMC Cancer. 2013 Jun 5;13:277. doi: 10.1186/1471-2407-13-277.

23.

Multiparameter DNA content analysis identifies distinct groups in primary breast cancer.

Dayal JH, Sales MJ, Corver WE, Purdie CA, Jordan LB, Quinlan PR, Baker L, ter Haar NT, Pratt NR, Thompson AM.

Br J Cancer. 2013 Mar 5;108(4):873-80. doi: 10.1038/bjc.2013.42. Epub 2013 Feb 14.

24.

Genome haploidisation with chromosome 7 retention in oncocytic follicular thyroid carcinoma.

Corver WE, Ruano D, Weijers K, den Hartog WC, van Nieuwenhuizen MP, de Miranda N, van Eijk R, Middeldorp A, Jordanova ES, Oosting J, Kapiteijn E, Hovens G, Smit J, van Wezel T, Morreau H.

PLoS One. 2012;7(6):e38287. doi: 10.1371/journal.pone.0038287. Epub 2012 Jun 1.

25.

Cervical carcinoma-associated fibroblasts are DNA diploid and do not show evidence for somatic genetic alterations.

Corver WE, Ter Haar NT, Fleuren GJ, Oosting J.

Cell Oncol (Dordr). 2011 Dec;34(6):553-63. doi: 10.1007/s13402-011-0061-5. Epub 2011 Nov 1.

26.

Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.

Middeldorp A, van Eijk R, Oosting J, Forte GI, van Puijenbroek M, van Nieuwenhuizen M, Corver WE, Ruano D, Caldes T, Wijnen J, Morreau H, van Wezel T.

Int J Cancer. 2012 Feb 15;130(4):837-46. doi: 10.1002/ijc.26093. Epub 2011 Jul 15.

27.

PTEN in colorectal cancer: a report on two Cowden syndrome patients.

Kersseboom R, Dubbink HJ, Corver WE, van Tilburg AJ, Poley JW, van Leerdam ME, Atmodimedjo PN, van de Laar IM, Collée JM, Dinjens WN, Morreau H, Wagner A.

Clin Genet. 2012 Jun;81(6):555-62. doi: 10.1111/j.1399-0004.2011.01639.x. Epub 2011 Mar 9.

PMID:
21291452
28.

High-resolution multiparameter DNA flow cytometry for the detection and sorting of tumor and stromal subpopulations from paraffin-embedded tissues.

Corver WE, ter Haar NT.

Curr Protoc Cytom. 2011 Jan;Chapter 7:Unit 7.37. doi: 10.1002/0471142956.cy0737s55.

PMID:
21207360
29.

Loss of CDC4/FBXW7 in gastric carcinoma.

Milne AN, Leguit R, Corver WE, Morsink FH, Polak M, de Leng WW, Carvalho R, Offerhaus GJ.

Cell Oncol. 2010;32(5-6):347-59. doi: 10.3233/CLO-2010-523.

30.

High-resolution multiparameter DNA flow cytometry for the detection and sorting of tumor and stromal subpopulations from paraffin-embedded tissues.

Corver WE, ter Haar NT.

Curr Protoc Cytom. 2009 Oct;Chapter 6:Unit 6.27. doi: 10.1002/0471142956.cy0627s50.

PMID:
19816924
31.

5-aminosalicylic acid interferes in the cell cycle of colorectal cancer cells and induces cell death modes.

Koelink PJ, Mieremet-Ooms MA, Corver WE, Wolanin K, Hommes DW, Lamers CB, Verspaget HW.

Inflamm Bowel Dis. 2010 Mar;16(3):379-89. doi: 10.1002/ibd.21086.

PMID:
19774649
32.

Single nucleotide polymorphisms in antigen processing machinery component ERAP1 significantly associate with clinical outcome in cervical carcinoma.

Mehta AM, Jordanova ES, Corver WE, van Wezel T, Uh HW, Kenter GG, Jan Fleuren G.

Genes Chromosomes Cancer. 2009 May;48(5):410-8. doi: 10.1002/gcc.20648.

PMID:
19202550
33.

Genome-wide allelic state analysis on flow-sorted tumor fractions provides an accurate measure of chromosomal aberrations.

Corver WE, Middeldorp A, ter Haar NT, Jordanova ES, van Puijenbroek M, van Eijk R, Cornelisse CJ, Fleuren GJ, Morreau H, Oosting J, van Wezel T.

Cancer Res. 2008 Dec 15;68(24):10333-40. doi: 10.1158/0008-5472.CAN-08-2665.

34.

The cytotoxic effect of phenol and ethanol on the chondrosarcoma-derived cell line OUMS-27: an in vitro experiment.

Verdegaal SH, Corver WE, Hogendoorn PC, Taminiau AH.

J Bone Joint Surg Br. 2008 Nov;90(11):1528-32. doi: 10.1302/0301-620X.90B11.21029.

PMID:
18978278
35.

High frequency of copy-neutral LOH in MUTYH-associated polyposis carcinomas.

Middeldorp A, van Puijenbroek M, Nielsen M, Corver WE, Jordanova ES, ter Haar N, Tops CM, Vasen HF, Lips EH, van Eijk R, Hes FJ, Oosting J, Wijnen J, van Wezel T, Morreau H.

J Pathol. 2008 Sep;216(1):25-31. doi: 10.1002/path.2375.

PMID:
18506705
36.

Expression of Smad2 and Smad4 in cervical cancer: absent nuclear Smad4 expression correlates with poor survival.

Kloth JN, Kenter GG, Spijker HS, Uljee S, Corver WE, Jordanova ES, Fleuren GJ, Gorter A.

Mod Pathol. 2008 Jul;21(7):866-75. doi: 10.1038/modpathol.2008.62. Epub 2008 Apr 18.

37.

Lack of TNFalpha mRNA expression in cervical cancer is not associated with loss of heterozygosity at 6p21.3, inactivating mutations or promoter methylation.

Kloth JN, Gorter A, ter Haar N, Corver WE, Jordanova ES, Kenter GG, Fleuren GJ.

Mol Immunol. 2008 Jan;45(1):152-9. Epub 2007 Jun 8.

PMID:
17560652
38.

Genetic variation of antigen processing machinery components and association with cervical carcinoma.

Mehta AM, Jordanova ES, van Wezel T, Uh HW, Corver WE, Kwappenberg KM, Verduijn W, Kenter GG, van der Burg SH, Fleuren GJ.

Genes Chromosomes Cancer. 2007 Jun;46(6):577-86.

PMID:
17366619
39.

High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.

de Boer MA, Jordanova ES, Kenter GG, Peters AA, Corver WE, Trimbos JB, Fleuren GJ.

Clin Cancer Res. 2007 Jan 1;13(1):132-8.

40.

High-resolution analysis of HLA class I alterations in colorectal cancer.

Dierssen JW, de Miranda NF, Mulder A, van Puijenbroek M, Verduyn W, Claas FH, van de Velde CJ, Jan Fleuren G, Cornelisse CJ, Corver WE, Morreau H.

BMC Cancer. 2006 Oct 2;6:233.

41.

Exclusion of RUNX3 as a tumour-suppressor gene in early-onset gastric carcinomas.

Carvalho R, Milne AN, Polak M, Corver WE, Offerhaus GJ, Weterman MA.

Oncogene. 2005 Dec 15;24(56):8252-8.

PMID:
16091737
42.

High-resolution multi-parameter DNA flow cytometry enables detection of tumour and stromal cell subpopulations in paraffin-embedded tissues.

Corver WE, Ter Haar NT, Dreef EJ, Miranda NF, Prins FA, Jordanova ES, Cornelisse CJ, Fleuren GJ.

J Pathol. 2005 Jun;206(2):233-41.

PMID:
15822070
44.

Flow cytometric sorting of paraffin-embedded tumor tissues considerably improves molecular genetic analysis.

Jordanova ES, Corver WE, Vonk MJ, Leers MP, Riemersma SA, Schuuring E, Kluin PM.

Am J Clin Pathol. 2003 Sep;120(3):327-34.

PMID:
14502796
45.

Software compensation improves the analysis of heterogeneous tumor samples stained for multiparameter DNA flow cytometry.

Corver WE, Fleuren GJ, Cornelisse CJ.

J Immunol Methods. 2002 Feb 1;260(1-2):97-107.

PMID:
11792380
46.

Simultaneous flow cytometric detection of DNA and cellular protein molecules.

Corver WE, Cornelisse CJ.

Methods Mol Med. 2001;39:515-28. doi: 10.1385/1-59259-071-3:515.

PMID:
21340808
47.

Molecular genetic analysis of flow-sorted and microdissected ovarian tumor cells improved detection of loss of heterozygosity.

Abeln EC, Corver WE.

Methods Mol Med. 2001;39:315-21. doi: 10.1385/1-59259-071-3:315.

PMID:
21340786
48.

Distinction between HLA class I-positive and -negative cervical tumor subpopulations by multiparameter DNA flow cytometry.

Corver WE, Koopman LA, Mulder A, Cornelisse CJ, Fleuren GJ.

Cytometry. 2000 Sep 1;41(1):73-80.

PMID:
10942899
49.

Allelotype analysis of flow-sorted breast cancer cells demonstrates genetically related diploid and aneuploid subpopulations in primary tumors and lymph node metastases.

Bonsing BA, Corver WE, Fleuren GJ, Cleton-Jansen AM, Devilee P, Cornelisse CJ.

Genes Chromosomes Cancer. 2000 Jun;28(2):173-83.

PMID:
10825002
50.

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer.

Koopman LA, Corver WE, van der Slik AR, Giphart MJ, Fleuren GJ.

J Exp Med. 2000 Mar 20;191(6):961-76.

Supplemental Content

Loading ...
Support Center